Cargando…
Neoadjuvant Therapy for Breast Cancer as a Model for Translational Research
Neoadjuvant therapy, where patients receive systemic therapy before surgical removal of the tumour, can downstage tumours allowing breast-conserving surgery, rather than mastectomy. In addition to its impact on surgery, the neoadjuvant setting offers a valuable opportunity to monitor individual tumo...
Autores principales: | Selli, Cigdem, Sims, Andrew H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381436/ https://www.ncbi.nlm.nih.gov/pubmed/30814840 http://dx.doi.org/10.1177/1178223419829072 |
Ejemplares similares
-
Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers
por: Selli, Cigdem, et al.
Publicado: (2016) -
Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours
por: Selli, Cigdem, et al.
Publicado: (2019) -
Differential expression of store-operated calcium- and proliferation-related genes in hepatocellular carcinoma cells following TRPC1 ion channel silencing
por: Selli, Cigdem, et al.
Publicado: (2016) -
Neoadjuvant systemic therapy for breast cancer
por: Zaborowski, Alexandra M, et al.
Publicado: (2023) -
Predicting response to neoadjuvant therapy with glucose transporter-1 in breast cancer
por: Öztürk, Seda Duman, et al.
Publicado: (2023)